Immunovant Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
8-K	Sep 3, 2026	8-K
4	Aug 28, 2026	FORM 4
4	Aug 21, 2026	FORM 4
SCHEDULE 13G/A	Aug 14, 2026
10-Q	Aug 6, 2026	10-Q
8-K	Aug 6, 2026	8-K
4	Jul 24, 2026	FORM 4
4	Jul 24, 2026	FORM 4
4	Jul 24, 2026	FORM 4
ARS	Jul 22, 2026	ARS
DEFA14A	Jul 22, 2026	DEFA14A
DEF 14A	Jul 22, 2026	DEF 14A
4	Jul 10, 2026	FORM 4
4	Jul 10, 2026	FORM 4
4	Jul 10, 2026	FORM 4
4	Jul 6, 2026	FORM 4
4	Jun 26, 2026	FORM 4
4	Jun 26, 2026	FORM 4
4	Jun 26, 2026	FORM 4
4	Jun 26, 2026	FORM 4
4	Jun 26, 2026	FORM 4
144	Jun 26, 2026
144	Jun 26, 2026
144	Jun 26, 2026
144	Jun 26, 2026

← Newer Page 1 of 26 · 641 filings Older →